淋巴结切除术在非巨块型淋巴结转移子宫内膜癌中的作用:全面手术分期与前哨淋巴结算法的比较
本研究回顾性比较了两家机构对IIIC期子宫内膜癌非巨块型淋巴结转移患者采用的两种淋巴结评估方式:系统性盆腔及腹主动脉旁淋巴结清扫术(LND队列,2004-2008年)与前哨淋巴结算法(SLN队列,2006-2013年)。共纳入104例患者(LND 48例,SLN 56例),校正辅助治疗类型后,LND组病因特异性死亡风险(HR 2.10,95%CI 0.79-5.58,P=0.14)和腹主动脉旁进展风险(HR 0.27,95%CI 0.05-1.42,P=0.12)均未达统计学显著,进展风险两组无显著差异(HR 1.27,95%CI 0.60-2.67,P=0.53)。作者认为SLN算法联合有限淋巴结清扫不损害生存,原发肿瘤侵袭性病理特征是最强预后决定因素。
要点
- IIIC期子宫内膜癌非巨块型淋巴结转移患者中,SLN算法联合有限淋巴结清扫与全面淋巴结清扫相比生存无显著差异。
- LND组病因特异性死亡风险HR 2.10(95%CI 0.79-5.58,P=0.14),腹主动脉旁进展风险HR 0.27(95%CI 0.05-1.42,P=0.12),均未达统计学显著。
- 原发肿瘤高危特征和非子宫内膜样类型是病因特异性生存和无进展生存的独立不良因素。
核心结论
- 在IIIC期子宫内膜癌非巨块型淋巴结转移患者中,采用SLN算法联合有限淋巴结清扫与系统性盆腔及腹主动脉旁淋巴结清扫相比不损害生存。
- 原发肿瘤的侵袭性病理特征是最强的预后决定因素。
研究设计与样本
- 回顾性识别两家机构治疗的IIIC期子宫内膜癌患者,共104例(LND队列48例,SLN队列56例)。
- 一家机构采用历史系列(2004-2008年)行系统性盆腔及腹主动脉旁淋巴结清扫术(LND队列)。
- 另一家机构采用较 contemporary 患者(2006-2013年)行前哨淋巴结算法(SLN队列)。
- 采用校正辅助治疗类型的Cox模型比较术后前5年内的结局(风险比[HR])。
主要发现
- 放化疗使用在两组相似(LND 46% vs SLN 50%),但单纯化疗(LND 19% vs SLN 36%)或单纯放疗(LND 15% vs SLN 2%)使用存在差异。
- LND组病因特异性死亡风险HR 2.10(95%CI 0.79-5.58,P=0.14),未达统计学显著。
- LND组腹主动脉旁进展风险HR 0.27(95%CI 0.05-1.42,P=0.12),未达统计学显著。
- 两组进展风险无显著差异(HR 1.27,95%CI 0.60-2.67,P=0.53)。
- 在多变量简约模型中,高危肿瘤特征和非子宫内膜样类型与病因特异性生存和无进展生存降低独立相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare survival and progression outcomes between 2 nodal assessment approaches in patients with nonbulky stage IIIC endometrial cancer (EC). METHODS: Patients with stage IIIC EC treated at 2 institutions were retrospectively identified. At 1 institution, a historical series (2004-2008) was treated with systematic pelvic and para-aortic lymphadenectomy (LND cohort). At the other institution, more contemporary patients (2006-2013) were treated using a sentinel lymph node algorithm (SLN cohort). Outcomes (hazard ratios [HRs]) within the first 5 years after surgery were compared between cohorts using Cox models adjusted for type of adjuvant therapy. RESULTS: The study included 104 patients (48 LND, 56 SLN). The use of chemoradiotherapy was similar in the 2 cohorts (46% LND vs 50% SLN), but the use of chemotherapy alone (19% vs 36%) or radiotherapy alone (15% vs 2%) differed. Although there was evidence of higher risk of cause-specific death (HR, 2.10; 95% CI, 0.79-5.58; P = 0.14) and lower risk of para-aortic progression (HR, 0.27; 95% CI, 0.05-1.42; P = 0.12) for the LND group, the associations did not meet statistical significance. The risk of progression was not significantly different between the groups (HR, 1.27; 95% CI, 0.60-2.67; P =0 .53). In parsimonious multivariable models, high-risk tumor characteristics and nonendometrioid type were independently associated with lower cause-specific survival and progression-free survival. CONCLUSIONS: In EC patients with nonbulky positive lymph nodes, use of the SLN algorithm with limited nodal dissection does not compromise survival compared with LND. Aggressive pathologic features of the primary tumor are the strongest determinants of prognosis.
引用
- Multinu F, Ducie JA, Eriksson AGZ, et al. Role of lymphadenectomy in endometrial cancer with nonbulky lymph node metastasis: Comparison of comprehensive surgical staging and sentinel lymph node algorithm. Gynecol Oncol. 2019. PMID: 31604668. doi:10.1016/j.ygyno.2019.09.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。